What is Veracyte's EPS (diluted)?

Veracyte (VCYT) reported EPS (diluted) of $0.35 in Q1 2026.

How has Veracyte's EPS (diluted) changed year-over-year?

Veracyte's EPS (diluted) increased by 288.9% year-over-year, from $0.09 to $0.35.

What is the long-term trend for Veracyte's EPS (diluted)?

Over 4 years (2021 to 2025), Veracyte's EPS (diluted) has grown at a -7.7% compound annual growth rate (CAGR), from -$1.13 to $0.82.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Veracyte VCYT EPS (Diluted)

EPS (Diluted) at other companies

Guardant HealthGH

-$0.85-10.4%

Natera, Inc.NTRA

-$0.60-20.0%

Bio-Rad LaboratoriesBIO

-$19.55-954%

RevvityRVTY

$0.36+2.9%

Labcorp HoldingsLH

$3.35+32.9%

Quest DiagnosticsDGX

$2.24+15.5%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's EPS (diluted)?: Veracyte (VCYT) reported EPS (diluted) of $0.35 in Q1 2026.
How has Veracyte's EPS (diluted) changed year-over-year?: Veracyte's EPS (diluted) increased by 288.9% year-over-year, from $0.09 to $0.35.
What is the long-term trend for Veracyte's EPS (diluted)?: Over 4 years (2021 to 2025), Veracyte's EPS (diluted) has grown at a -7.7% compound annual growth rate (CAGR), from -$1.13 to $0.82.
What does EPS (diluted) mean?: Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.